TY - JOUR
T1 - Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin
AU - Willcutts, Michael D.
AU - Felner, Eric
AU - White, Perrin C.
N1 - Funding Information:
We thank Dr Mariel Birnbaumer (UCLA) for the LV2 cell line, Dr Raj Pandian (Quest Diagnostics) for performing radioimmunoassays of Leu-AVP and Dr Clive Slaughter (UT South-western) for HPLC and amino acid analysis of Leu-AVP. This work was supported by grant R37 DK37867 from the National Institutes of Health.
PY - 1999
Y1 - 1999
N2 - Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post natal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene. All published mutations affect the signal peptide or the neurophysin-II carrier protein and are presumed to interfere with processing of the preprohormone, leading to neuronal damage. We studied an unusual Palestinian family consisting of asymptomatic first cousin parents and three children affected with neurohypophyseal diabetes insipidus, suggesting autosomal recessive inheritance. All three affected children were homozygous and the parents heterozygous for a single novel mutation (C301→T) in exon 1, replacing Pro7 of mature AVP with Leu (Leu-AVP). Leu-AVP was a weak agonist with ~ 30-fold reduced binding to the human V2 receptor. Measured by radioimmunoassay with a synthetic Leu-AVP standard, serum Leu-AVP levels were elevated in all three children and further increased during water deprivation to as high as 30 times normal. The youngest child (2 years old) was only mildly affected but had Leu-AVP levels similar to her severely affected 8-year-old brother, suggesting that unknown mechanisms may partially compensate for a deficiency of active AVP in very young children.
AB - Familial neurohypophyseal diabetes insipidus is an autosomal dominant disorder characterized by post natal development of arginine vasopressin (AVP) deficiency due to mutations in the AVP gene. All published mutations affect the signal peptide or the neurophysin-II carrier protein and are presumed to interfere with processing of the preprohormone, leading to neuronal damage. We studied an unusual Palestinian family consisting of asymptomatic first cousin parents and three children affected with neurohypophyseal diabetes insipidus, suggesting autosomal recessive inheritance. All three affected children were homozygous and the parents heterozygous for a single novel mutation (C301→T) in exon 1, replacing Pro7 of mature AVP with Leu (Leu-AVP). Leu-AVP was a weak agonist with ~ 30-fold reduced binding to the human V2 receptor. Measured by radioimmunoassay with a synthetic Leu-AVP standard, serum Leu-AVP levels were elevated in all three children and further increased during water deprivation to as high as 30 times normal. The youngest child (2 years old) was only mildly affected but had Leu-AVP levels similar to her severely affected 8-year-old brother, suggesting that unknown mechanisms may partially compensate for a deficiency of active AVP in very young children.
UR - http://www.scopus.com/inward/record.url?scp=0032805975&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032805975&partnerID=8YFLogxK
U2 - 10.1093/hmg/8.7.1303
DO - 10.1093/hmg/8.7.1303
M3 - Article
C2 - 10369876
AN - SCOPUS:0032805975
SN - 0964-6906
VL - 8
SP - 1303
EP - 1307
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 7
ER -